Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies
Laura Fusar‐Poli, Vito Cavone, Silvia Tinacci, et al.
Brain Sciences (2020) Vol. 10, Iss. 9, pp. 572-572
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Cannabinoid treatment for autism: a proof-of-concept randomized trial
Adi Aran, Moria Harel, Hanoch Cassuto, et al.
Molecular Autism (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 140
THC and CBD: Similarities and differences between siblings
Nephi Stella
Neuron (2023) Vol. 111, Iss. 3, pp. 302-327
Open Access | Times Cited: 57
Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics
Anne Katrin Schlag, Saoirse E. O’Sullivan, Rayyan Zafar, et al.
Neuropharmacology (2021) Vol. 191, pp. 108586-108586
Closed Access | Times Cited: 64
Review: Cannabinoids as Medicinals
Jag Khalsa, Gregory Bunt, Kenneth Blum, et al.
Current Addiction Reports (2022) Vol. 9, Iss. 4, pp. 630-646
Open Access | Times Cited: 42
An overview on synthetic and biological activities of cannabidiol (CBD) and its derivatives
Xiuli Wang, Huanbang Zhang, Yan Liu, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106810-106810
Closed Access | Times Cited: 26
The Impact of Cannabidiol on Human Brain Function: A Systematic Review
Albert Batalla, Julian Bos, Amber Postma, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 49
A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders
CM Díaz-Caneja, Matthew W. State, RJ Hagerman, et al.
European Neuropsychopharmacology (2021) Vol. 48, pp. 49-88
Open Access | Times Cited: 42
CBD in the Treatment of Epilepsy
Kinga K. Borowicz-Reutt, Julia Czernia, Marlena Krawczyk
Molecules (2024) Vol. 29, Iss. 9, pp. 1981-1981
Open Access | Times Cited: 6
Endocannabinoid System Changes throughout Life: Implications and Therapeutic Potential for Autism, ADHD, and Alzheimer’s Disease
Kamila Gabrieli Dallabrida, Jeane Maria de Oliveira, Ellen Schavarski Chade, et al.
Brain Sciences (2024) Vol. 14, Iss. 6, pp. 592-592
Open Access | Times Cited: 6
Efficacy of cannabinoids in neurodevelopmental and neuropsychiatric disorders among children and adolescents: a systematic review
Lauren Rice, Lisa Cannon, Navin Dadlani, et al.
European Child & Adolescent Psychiatry (2023) Vol. 33, Iss. 2, pp. 505-526
Open Access | Times Cited: 14
Cannabidiol and cannabis-inspired terpene blends have acute prosocial effects in the BTBR mouse model of autism spectrum disorder
Jenika Staben, Megan Koch, Keelee Reid, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 14
Decades of Progress in the Psychopharmacology of Autism Spectrum Disorder
Erin A. Henneberry, Martine Lamy, Kelli C. Dominick, et al.
Journal of Autism and Developmental Disorders (2021) Vol. 51, Iss. 12, pp. 4370-4394
Closed Access | Times Cited: 27
CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature
Serap Bilge, Barış Ekici
Journal of Cannabis Research (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 27
The Current View on the Paradox of Pain in Autism Spectrum Disorders
Olena V. Bogdanova, Volodymyr B. Bogdanov, Adrien Pizano, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 20
Purified cannabidiol leads to improvement of severe treatment-resistant behavioral symptoms in children with autism spectrum disorder
Pablo Sebastián Fortini, Javier J Toibaro, Roberto Caraballo
Pharmacology Biochemistry and Behavior (2025) Vol. 249, pp. 173971-173971
Closed Access
Psychopharmacology in Autism
Katherine J. Zappia, Craig A. Erickson
(2025), pp. 315-340
Closed Access
Efficacy and Safety of Cannabinoids for Autism Spectrum Disorder: An Updated Systematic Review
Danilo Assis Pereira, Lídia Cheidde, Mateus Daniel R Megiolaro, et al.
Cureus (2025)
Open Access
BEHAVIORAL AND TRANSCRIPTOMIC EFFECTS OF A NOVEL CANNABINOID ON A RAT VALPROIC ACID MODEL OF AUTISM
Sally Loomis, Dylan E. Da Silva, Ranjev Savopoulos, et al.
Neuropharmacology (2025), pp. 110450-110450
Closed Access
Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry
Simon Erridge, Jess Kerr‐Gaffney, Carl Holvey, et al.
Therapeutic Advances in Psychopharmacology (2022) Vol. 12
Open Access | Times Cited: 18
Lipid-Based Molecules on Signaling Pathways in Autism Spectrum Disorder
Kunio Yui, George Imataka, Shigemi Yoshihara
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9803-9803
Open Access | Times Cited: 17
Advances in the Treatment of Autism Spectrum Disorder: Current and Promising Strategies
Konstantin Yenkoyan, Zadik Ounanian, Margarita Mirumyan, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 12, pp. 1485-1511
Open Access | Times Cited: 9
Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder
Erica Zamberletti, Tiziana Rubino, Daniela Parolaro
Pharmacology & Therapeutics (2021) Vol. 226, pp. 107878-107878
Closed Access | Times Cited: 23
Increasing Endocannabinoid Tone Alters Anxiety-Like and Stress Coping Behaviour in Female Rats Prenatally Exposed to Valproic Acid
Aoife M. Thornton, Rachel M. Humphrey, Daniel M. Kerr, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3720-3720
Open Access | Times Cited: 21
Role of Brain Modulators in Neurodevelopment: Focus on Autism Spectrum Disorder and Associated Comorbidities
Ali Saad, Amal Akour, Abdulla Mahboob, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 612-612
Open Access | Times Cited: 15
Medicinal cannabis in children and adolescents with autism spectrum disorder: A scoping review
Sarah Fletcher, Colleen Pawliuk, Angie Ip, et al.
Child Care Health and Development (2021) Vol. 48, Iss. 1, pp. 33-44
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top